Effect of Lipid Composition on the Atheroprotective Properties of HDL-Mimicking Micelles
dc.contributor.author | Hong, K | |
dc.contributor.author | Yu, M | |
dc.contributor.author | Crowther, J | |
dc.contributor.author | Mei, L | |
dc.contributor.author | Olsen, K | |
dc.contributor.author | Luo, Y | |
dc.contributor.author | Chen, YE | |
dc.contributor.author | Guo, Y | |
dc.contributor.author | Schwendeman, A | |
dc.coverage.spatial | Switzerland | |
dc.date.accessioned | 2023-01-09T16:21:17Z | |
dc.date.available | 2023-01-09T16:21:17Z | |
dc.date.issued | 2022-08-01 | |
dc.identifier.issn | 1999-4923 | |
dc.identifier.issn | 1999-4923 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/36015196 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/175361 | en |
dc.description.abstract | Atherosclerosis progression is driven by an imbalance of cholesterol and unresolved local inflammation in the arteries. The administration of recombinant apolipoprotein A-I (ApoA-I)-based high-density lipoprotein (HDL) nanoparticles has been used to reduce the size of atheroma and rescue inflammatory response in clinical studies. Because of the difficulty in producing large quantities of recombinant ApoA-I, here, we describe the preparation of phospholipid-based, ApoA-I-free micelles that structurally and functionally resemble HDL nanoparticles. Micelles were prepared using various phosphatidylcholine (PC) lipids combined with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[azido(polyethylene glycol)-2000] (DSPE-PEG2k) to form nanoparticles of 15–30 nm in diameter. The impacts of PC composition and PEGylation on the anti-inflammatory activity, cholesterol efflux capacity, and cholesterol crystal dissolution potential of micelles were investigated in vitro. The effects of micelle composition on pharmacokinetics and cholesterol mobilization ability were evaluated in vivo in Sprague Dawley rats. The study shows that the composition of HDL-mimicking micelles impacts their overall atheroprotective properties and supports further investigation of micelles as a therapeutic for the treatment of atherosclerosis. | |
dc.format.medium | Electronic | |
dc.language | eng | |
dc.publisher | MDPI | |
dc.relation.haspart | ARTN 1570 | |
dc.rights | Licence for published version: Creative Commons Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | atherosclerosis | |
dc.subject | high-density lipoproteins | |
dc.subject | lipid composition | |
dc.subject | micelle | |
dc.subject | nanoparticle | |
dc.title | Effect of Lipid Composition on the Atheroprotective Properties of HDL-Mimicking Micelles | |
dc.type | Article | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/175361/2/pharmaceutics-14-01570.pdf | |
dc.identifier.doi | 10.3390/pharmaceutics14081570 | |
dc.identifier.doi | https://dx.doi.org/10.7302/6742 | |
dc.identifier.source | Pharmaceutics | |
dc.description.version | Published version | |
dc.date.updated | 2023-01-09T16:21:14Z | |
dc.identifier.orcid | 0000-0003-2357-7825 | |
dc.identifier.orcid | 0000-0002-3334-9159 | |
dc.identifier.orcid | 0000-0002-8023-8080 | |
dc.identifier.volume | 14 | |
dc.identifier.issue | 8 | |
dc.identifier.startpage | 1570 | |
dc.identifier.name-orcid | Hong, K | |
dc.identifier.name-orcid | Yu, M | |
dc.identifier.name-orcid | Crowther, J | |
dc.identifier.name-orcid | Mei, L | |
dc.identifier.name-orcid | Olsen, K | |
dc.identifier.name-orcid | Luo, Y | |
dc.identifier.name-orcid | Chen, YE; 0000-0003-2357-7825 | |
dc.identifier.name-orcid | Guo, Y; 0000-0002-3334-9159 | |
dc.identifier.name-orcid | Schwendeman, A; 0000-0002-8023-8080 | |
dc.working.doi | 10.7302/6742 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.